cyclohexanol has been researched along with unc2250 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cummings, C; DeRyckere, D; Earp, HS; Frye, SV; Graham, DK; Hunter, D; Janzen, WP; Kireev, D; Kirkpatrick, G; Lee, M; Machius, M; Miley, MJ; Norris-Drouin, J; Sather, S; Stashko, MA; Stewart, WM; Wang, X; Zhang, D; Zhang, W; Zhou, Y | 1 |
| Abbassi, R; Baell, J; Day, BW; Frye, S; Hoque, M; Munoz, L; Nguyen, N; Recasens, A; Stashko, MA; Wai Wong, S; Wang, X; Zhang, D | 1 |
| Du, Q; Du, Y; Jiang, L; Lu, Z; Shen, Y; Wang, D; Yang, D; Yu, W | 1 |
3 other study(ies) available for cyclohexanol and unc2250
| Article | Year |
|---|---|
Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors.
Topics: Antineoplastic Agents; c-Mer Tyrosine Kinase; Cell Line, Tumor; Cyclization; Cyclohexanols; Drug Design; Humans; Hydrogen Bonding; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship | 2013 |
MerTK activity is not necessary for the proliferation of glioblastoma stem cells.
Topics: Animals; c-Mer Tyrosine Kinase; Cell Line, Tumor; Cell Proliferation; Cyclohexanols; Dose-Response Relationship, Drug; Glioblastoma; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrimidines; Xenograft Model Antitumor Assays | 2021 |
MerTK inhibits the activation of the NLRP3 inflammasome after subarachnoid hemorrhage by inducing autophagy.
Topics: Animals; Autophagy; Brain; c-Mer Tyrosine Kinase; Cell Line; Cyclohexanols; Male; Mice; Mice, Inbred C57BL; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein; Pyrimidines; Subarachnoid Hemorrhage | 2021 |